Center for Inherited Blood Disorders (CIBD) Site Number : 8400012 — Orange, California

Center for Inherited Blood Disorders (CIBD) Site Number : 8400012 is a clinical research site located in Orange, California, United States 92868-4306.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Center for Inherited Blood Disorders (CIBD) Site Number : 8400012 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hemophilia.

Sponsors: Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Orange

Browse all research sites in California · View every site in Orange

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Center for Inherited Blood Disorders (CIBD) Site Number : 8400012?

Center for Inherited Blood Disorders (CIBD) Site Number : 8400012 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Center for Inherited Blood Disorders (CIBD) Site Number : 8400012 conducted?

Center for Inherited Blood Disorders (CIBD) Site Number : 8400012 has 1 clinical trials on record, with 1 currently active. Their work covers Hemophilia.

Is Center for Inherited Blood Disorders (CIBD) Site Number : 8400012 accredited by Crixeo Clinical Trials?

Center for Inherited Blood Disorders (CIBD) Site Number : 8400012 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Center for Inherited Blood Disorders (CIBD) Site Number : 8400012?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.